| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5701962 | Journal of Thoracic Oncology | 2017 | 28 Pages | 
Abstract
												STAS was present in one-third of resected lung SCCs. In competing risks analysis in a cohort in which three-fourths of the patients were elderly, STAS was associated with lung cancer-specific outcomes. Our findings suggest that STAS is one of the most prognostically significant histologic findings in lung SCC.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Shaohua MD, Kay See PhD, Kyuichi MD, Takashi MD, PhD, Sarina MD, Natasha MD, PhD, Prasad S. MD, William D. MD, 
											